agilon health, inc. (AGL)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 22, 2026

Verified against EDGAR
Total Assets
$1.59B
Stockholders' Equity
$227.5M
Cash & Equivalents
$107.2M
Long-Term Debt
$15.4M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, agilon health, inc. reported revenue of $1.49B, net income of $18.0M, and total assets of $1.59B. Every figure below is taken directly from agilon health, inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2019–FY2025 · as reported

$6.06B$2.83B-$406.5M
FY2019FY2021FY2023FY2025
Revenue$5.93BNet income-$391.3M
FY2019 revenue
$794.4M
FY2025 revenue
$5.93B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$5.93B-$391.3M
FY2024$6.06B-$260.2M
FY2023$4.32B-$262.6M
FY2022$2.39B-$106.6M
FY2021$1.52B-$406.5M
FY2020$1.22B-$60.1M
FY2019$794.4M-$282.6M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 5, 2026on EDGAR ↗
10-QAug 5, 2026on EDGAR ↗
8-KJul 21, 2026on EDGAR ↗
8-KJun 3, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
8-KMay 6, 2026on EDGAR ↗
8-KApr 27, 2026on EDGAR ↗
DEF 14AApr 22, 2026on EDGAR ↗
8-KMar 30, 2026on EDGAR ↗
8-KMar 18, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$1.59Bsource ↗
Stockholders’ Equity$227.5Msource ↗
Cash & Equivalents$107.2Msource ↗
Long-Term Debt$15.4Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$1.49Bsource ↗
Net Income$18.0Msource ↗
Operating Income$11.8Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense—source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$1.04source ↗
EPS (basic)$1.07source ↗
Shares Outstanding16.8Msource ↗
Cash from Operations-$57.3Msource ↗
Cash from Financing$4.6Msource ↗
Cash from Investing$19.9Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

No open-market Form 4 transactions filed in the last 180 days.

Restatement history

Point-in-time

9 of 175 annual fact-keys were materially restated between filings: what agilon health, inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches AGL’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AGL

MCP tool: get_sec_fundamentals ticker=AGL

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AGL/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=AGL as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AGL/history

MCP tool: get_fundamentals_history ticker=AGL

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/AGL

MCP tool: get_financial_health ticker=AGL

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.